The complicated task of monitoring vaccine safety
- PMID: 9018282
- PMCID: PMC1381831
The complicated task of monitoring vaccine safety
Abstract
Vaccination is an essential component of modern public health programs and is among our most cost-effective medical interventions. Yet despite vaccines' clear effectiveness in reducing risks of diseases that previously attacked large proportions of the population, caused many deaths, and left many people with permanent disabilities, current vaccination policies are not without controversy. Vaccines, like all other pharmaceutical products, are not entirely risk-free; while most known side effects are minor and self-limited, some vaccines have been associated with very rare but serious adverse effects. Because such rare effects are often not evident until vaccines come into widespread use, the Federal government maintains ongoing surveillance programs to monitor vaccine safety. The interpretation of data from such programs is complex and is associated with substantial uncertainty. A continual effort to monitor these data effectively and to develop more precise ways of assessing risks of vaccines is necessary to ensure public confidence in immunization programs.
Similar articles
-
Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.Pediatrics. 2011 May;127 Suppl 1:S65-73. doi: 10.1542/peds.2010-1722J. Epub 2011 Apr 18. Pediatrics. 2011. PMID: 21502239
-
Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).J Clin Neuromuscul Dis. 2009 Sep;11(1):1-6. doi: 10.1097/CND.0b013e3181aaa968. J Clin Neuromuscul Dis. 2009. PMID: 19730016
-
Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.MMWR Morb Mortal Wkly Rep. 2009 Dec 11;58(48):1351-6. MMWR Morb Mortal Wkly Rep. 2009. PMID: 20010511
-
Monitoring and assessing vaccine safety: a European perspective.Expert Rev Vaccines. 2010 Apr;9(4):371-80. doi: 10.1586/erv.10.20. Expert Rev Vaccines. 2010. PMID: 20370548 Review.
-
Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS.Expert Rev Vaccines. 2009 Jun;8(6):705-16. doi: 10.1586/erv.09.40. Expert Rev Vaccines. 2009. PMID: 19485752 Review.
Cited by
-
Monitoring the safety of vaccines: assessing the risks.Drug Saf. 2002;25(3):145-52. doi: 10.2165/00002018-200225030-00001. Drug Saf. 2002. PMID: 11945111
-
A comparative analysis on serious adverse events reported for COVID-19 vaccines in adolescents and young adults.Front Public Health. 2023 Jun 12;11:1145645. doi: 10.3389/fpubh.2023.1145645. eCollection 2023. Front Public Health. 2023. PMID: 37377545 Free PMC article.
-
Safety of routine childhood vaccinations. An epidemiological review.Paediatr Drugs. 2000 Jul-Aug;2(4):273-90. doi: 10.2165/00128072-200002040-00004. Paediatr Drugs. 2000. PMID: 10946416 Review.
-
Epigenetics and Metabolism Reprogramming Interplay into Glioblastoma: Novel Insights on Immunosuppressive Mechanisms.Antioxidants (Basel). 2023 Jan 18;12(2):220. doi: 10.3390/antiox12020220. Antioxidants (Basel). 2023. PMID: 36829778 Free PMC article. Review.
-
Myocarditis and Pericarditis Post-mRNA COVID-19 Vaccination: Insights from a Pharmacovigilance Perspective.J Clin Med. 2023 Jul 28;12(15):4971. doi: 10.3390/jcm12154971. J Clin Med. 2023. PMID: 37568373 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical